Virax Biolabs Group Ltd
Specializes in T-cell immunity tests and diagnostics for profiling viral disease responses.
VRAX | NDAQ
Overview
Corporate Details
- ISIN(s):
- KYG9470A1094
- LEI:
- Country:
- United States of America
- Address:
- BIOCITY GLASGOW, LANARKSHIRE
- Website:
- https://www.viraxbiolabs.com
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Virax Biolabs Group Ltd. is a biotechnology company specializing in the detection and profiling of immune responses to viral diseases. The company focuses on T-cell immunity, engaging in the research and development of T-cell-based tests for immunology profiling. Its core offering is the ViraxImmune™ platform, an in-vitro diagnostic (IVD) tool for the detailed study and characterization of innate and adaptive immune responses. In addition to its proprietary R&D, the company also sells, distributes, and markets diagnostic test kits. Through its services, including sensitive ELISpot assays, Virax Biolabs aims to provide crucial insights into disease mechanisms and accelerate the development of more effective vaccines and therapeutic strategies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Virax Biolabs Group Ltd filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Virax Biolabs Group Ltd
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Virax Biolabs Group Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
